Home  >  Products  >  LYZ (lysozyme (renal amyloidosis)) Blocking Peptide (the C terminal of LYZ)(100ug)
LYZ (lysozyme (renal amyloidosis)) Blocking Peptide (the C terminal of LYZ)(100ug)

LYZ (lysozyme (renal amyloidosis)) Blocking Peptide (the C terminal of LYZ)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LYZ Antibody (ARP60297_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60297
Size: 100ug
Weight: 15kDa
Gene: 4069
Format: Lyophilized powder
Target: LYZ is a human lysozyme, whose natural substrate is the bacterial cell wall peptidoglycan (cleaving the beta[1-4]glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine). Lysozyme is one of the anti-microbial agents found in human milk, and is also present in spleen, lung, kidney, white blood cells, plasma, saliva, and tears. Missense mutations in LYZ have been identified in heritable renal amyloidosis.
Alternative names: LZM; lysozyme
See Full Product Listings >